The Kenya Medical Research Institute (Kemri) has begun a clinical study to test whether two available drugs in the market can treat Covid-19 patients with mild and moderate symptoms in Africa.
The trial, ANTICOV, being conducted in 19 sites in 13 African countries will begin testing, against a control arm, the HIV anti-retroviral combination lopinavir/ritonavir and the malaria drug hydroxychloroquine, which remains the standard of care for Covid-19 today in numerous African countries.
...
AllAfrica Subscription Content
You must be an allAfrica.com subscriber for full access to certain content.
You have selected an article from the AllAfrica archive, which requires a subscription. You can subscribe by visiting our subscription page. Or for more information about becoming a subscriber, you can read our subscription and contribution overview.
For information about our premium subscription services:
You can also freely access - without a subscription - hundreds of today's top Africa stories and thousands of recent news articles from our home page »
Already a subscriber? Sign in for full access to article